4//SEC Filing
CROSS HERB 4
Accession 0001213900-25-014949
CIK 0001788028other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:30 PM ET
Size
5.7 KB
Accession
0001213900-25-014949
Insider Transaction Report
Form 4
CROSS HERB
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-13+50,000→ 50,000 totalExercise: $6.20Exp: 2035-02-13→ Voting Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001230721
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:30 PM ET
- Size
- 5.7 KB